entity

T2D

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about T2D: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
0Hypotheses
0Analyses
1Outgoing
2Incoming

Wiki Pages (16)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Protein O-GlcNAcylation Pathway in Neurodegeneration

mechanism · 3298 words

Amylin Signaling in Neurodegeneration

mechanism · 2986 words

Semaglutide Phase 3 Alzheimer's Trial (EVOKE Plus, NCT04777409)

clinical · 2562 words

Outgoing (1)

TargetRelationTypeStr
ADassociated_withdisease0.64

Incoming (2)

SourceRelationTypeStr
OXIDATIVE STRESScausesprocess0.80
HSPA1Aassociated_withprotein0.72

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found